Spironolactone Tablet, Coated
Product Images NDC 53401-041

5 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53401-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (53401 0041 30)

Label (53401 0041 30)
Spironolactone USP 25 mg coated tablets packaging label showing a 30-tablet bottle. Manufactured by Oxford Pharmaceuticals, LLC, Birmingham, AL, and packaged by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. The label includes storage instructions, NDC 53401-041-30, and indicates the product is for prescription use only.*
FDA Label Image

Aphena (Aphena)

Aphena (Aphena)
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival probability curve comparing Spironolactone (n=822) and placebo (n=841) over time in months. The graph displays decreasing survival probabilities for both groups, with Spironolactone showing higher survival over 36 months. Statistical significance is indicated by a log-rank p-value less than 0.001.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing Spironolactone versus placebo. The subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4, indicating the effect direction where Spironolactone or placebo is favored.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure of the active ingredient spironolactone, depicting its steroidal core and attached functional groups as shown in the molecular diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.